Council Members in this Study Group: 2077
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
President
Pharmacy Benefit Advisors ![]()
Bruce Goldberg is the President of Pharmacy Express Services and Pharmacy Benefit Advisors, both based in Omaha, Nebraska. He is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He developed a program which allows generic and therapeuticsubstitution...
VP Operations
CUMBERLAND PHARMACEUTICALS, INC. ![]()
Leo Pavliv, RPh, MBA, is Vice President Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical and non-clinical development, manufacturing, and quality...
President/Owner
Doctors of Pharmacy, Inc. ![]()
David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30 years of experience, specializing in pharmacyservices...
Michael Kuller, RPhPresident
Allstar Oxygen Services Inc ![]()
Michael Kuller, RPh, is the President of Allstar Oxygen Services, a private home oxygen, CPAP and medical equipment company, in Northern California, since November 1999. Allstar Oxygen Services was recognized as a growing private company in the SF Bay Area between 2000 and 2003. In 1982, Mr. Kuller...
Dea Belazi, PharmD, MPH, PAHMPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM ![]()
Dea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...
Steven Miller, MS, DPHPresident
Steven Miller, MS, DPH ![]()
Steven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement issues, where he is working since February...
Tim Gallagher, RPhExecutive Vice President of Pharmacy Operations
ASTRUP DRUG, INC. ![]()
Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug in Minnesota, since 1999. Mr. Gallagher manages all aspects of pharmacy operations for the company. He has been a practicing pharmacist for over 25 years in both the chain and independent community pharmacy setting...
President
MindPharma ![]()
Aemad Aslam, BPharm, MBA, RPh, is the President of MindPharma, a pharmacy and retail strategy consulting group. Most recently, he has consulted with a PBM, Prime Therapeutics, in Texas, a subsidiary of Blue Cross Blue Shield. He also has served as an Executive Team Leader for Pharmacy at the Target...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Express Scripts feeling Growing Pains
October 29, 2009
Express Scripts to Close NextRx Deal in 4Q | quicktake.morningstar.com
On 11/04/09 TriCare, the health insurance plan for the US Military and its families are being moved to a new pharmacy benefit administered by Express Scripts. Despite assurances of transparency and no change in pharmacies, thousands of beneficiaries are being directed by Express Scripts to a single...
Particle Beam Radiation Therapy (PBRT) life saving technology but who will pay?
October 22, 2009
Particle Beam Radiation Therapy published by AHRQ | effectivehealthcare.ahrq.gov
PBRT is an exciting technology that has emerged as a life saver for children and many adults with head/neck , eye and other difficult to treat cancers. Proton Centers require massive investments from $100-250 million. Payor groups from Medicare to commercial plans are faced with whether to pay forthis...
Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone
April 13, 2009
Aemad Aslam, MBA, President, MindPharma
Sun Pharma gets USFDA's nod to market painkillers | www.hindu.com
Sun Pharma can greatly benefit from the nationwide shortage of Oxycodone Immediate Release Tablet, by getting approval from the FDA on their own generic. With recent recalls from different manufacturers, and the shortage of a comparable product Morphine Sulphate, the FDA currently estimates that return...
Aurobindo Pharma's Escitalopram will be a big mover ... when it comes out in 2011
March 5, 2009
Aemad Aslam, MBA, President, MindPharma
Aurobindo Pharma receives tentative approval for Escitalopram | www.indiainfoline.com
Forest's Lexapro commands a $2.5+ billion USD market share, just in the US. Due to such a high volume of the brand product, Aurobindo's tentative approval on Lexapro's generic Escitalopram will be a great opportunity - primarily if they can procure a 6 month period of exclusivity from the FDA. ...
Teva's Generic Imitrex commands market of Sumatriptan
February 26, 2009
Aemad Aslam, MBA, President, MindPharma
Teva Announces Approval and Launch of Generic Imitrex(R) Tablets | www.pipelinereview.com
With the 180 day exclusivity, Teva is already commanding the market of the generic Imitrex - Sumatriptan oral tablets. Teva maintains an AB rating of the generic that will render most insurance companies to push brand name Imitrex by GlaxoSmithKline to a non-formulary tier, skyrocketing the...
| Study Group Name | No. Members |
|---|---|
| Pharmacists at Hospitals | 634 |
| Pharmacists at Non-academic Hospitals | 412 |
| Generic Drug Economic Experts | 766 |
| Experts on Generic Pharmaceuticals: Pharmacists | 106 |
| Formulary Design Experts | 250 |
| Economic Experts on Managed Care | 714 |
| Medicare Experts | 493 |
Leading Experts in Pharmacists (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Pharmacists (US) have not participated in any GLG webcasts.